Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.51% |
| 2 | Consumer Discretionary | 7.62% |
| 3 | Energy | 7.06% |
| 4 | Technology | 6.57% |
| 5 | Industrials | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCIC
4876
BCP Investment Corp
BCIC
$95.6M
| $156K | ﹤0.01% |
+1,735
| New | +$165K |
|
|
CMD
4877
CALL
DELISTED
Cantel Medical Corporation
CMD
| $156K | ﹤0.01% |
+4,900
| New | +$130K |
|
4878
Scotiabank
BNS
$110B
| $155K | ﹤0.01% |
2,901
-16,298
| -85% | -$851K |
|
|
CPHD
4879
DELISTED
Cepheid Inc
CPHD
| $155K | ﹤0.01% |
3,972
-5,791
| -59% | -$210K |
|
4880
PUT
Belden
BDC
$5.39B
| $154K | ﹤0.01% |
2,400
+200
| +9% | +$11.7K |
|
4881
Fuel Tech
FTEK
$45.9M
| $154K | ﹤0.01% |
35,218
-7,493
| -18% | -$29.8K |
|
4882
PUT
NovaGold Resources
NG
$3.45B
| $154K | ﹤0.01% |
66,300
-2,400
| -3% | -$6.27K |
|
4883
PUT
Valley National Bancorp
VLY
$8.25B
| $154K | ﹤0.01% |
15,500
-5,700
| -27% | -$57.6K |
|
|
END
4884
CALL
DELISTED
ENDEAVOUR INTERNATIONAL CORP NEW (NV)
END
| $154K | ﹤0.01% |
28,700
+13,800
| +93% | +$67.3K |
|
|
LPNT
4885
PUT
DELISTED
LifePoint Health, Inc.
LPNT
| $154K | ﹤0.01% |
3,300
-800
| -20% | -$38.3K |
|
4886
CALL
American Water Works
AWK
$26.8B
| $153K | ﹤0.01% |
3,700
-3,900
| -51% | -$161K |
|
4887
CALL
Semtech
SMTC
$12.4B
| $153K | ﹤0.01% |
5,100
-10,800
| -68% | -$340K |
|
|
ABMD
4888
CALL
DELISTED
Abiomed Inc
ABMD
| $153K | ﹤0.01% |
8,000
-7,100
| -47% | -$162K |
|
|
AVNR
4889
CALL
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $153K | ﹤0.01% |
36,100
+25,300
| +234% | +$120K |
|
4890
PUT
eHealth
EHTH
$39.7M
| $152K | ﹤0.01% |
4,700
+4,500
| +2,250% | +$124K |
|
|
FMER
4891
CALL
DELISTED
FIRSTMERIT CORP
FMER
| $152K | ﹤0.01% |
7,000
+5,300
| +312% | +$115K |
|
|
STRI
4892
DELISTED
STR HLDGS INC COM STK NEW (DE)
STRI
| $152K | ﹤0.01% |
22,724
+239
| +1% | +$1.54K |
|
4893
American Superconductor
AMSC
$1.56B
| $151K | ﹤0.01% |
6,437
+2,890
| +81% | +$73.2K |
|
|
4894
Bank of America Series L
BAC.PRL
$4.01B
| $151K | ﹤0.01% |
+140
| New | +$153K |
|
4895
CALL
Guidewire Software
GWRE
$14.4B
| $151K | ﹤0.01% |
+3,200
| New | +$144K |
|
|
POZN
4896
DELISTED
POZEN INC
POZN
| $151K | ﹤0.01% |
26,343
+19,320
| +275% | +$107K |
|
4897
CALL
Equifax
EFX
$21.2B
| $150K | ﹤0.01% |
2,500
-300
| -11% | -$18.5K |
|
4898
CALL
Helen of Troy
HELE
$696M
| $150K | ﹤0.01% |
3,400
-6,200
| -65% | -$261K |
|
4899
PUT
Kaiser Aluminum
KALU
$2.99B
| $150K | ﹤0.01% |
2,100
+1,600
| +320% | +$108K |
|
4900
PUT
Live Nation Entertainment
LYV
$43.2B
| $150K | ﹤0.01% |
8,100
-700
| -8% | -$11.9K |
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.
By sector, the portfolio is most concentrated in Financials at 9.5% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Energy.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 735 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.